SCHEMBL3715550

SCHEMBL3715550

CC(SCC(N)C(=O)O)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.48
SLC1A3 P43003 4/20 0.43
SLC1A2 P43004 4/20 0.43
SLC1A1 P43005 3/20 0.43
ARG1 P05089 1/20 0.42
ARG2 P78540 1/20 0.42
KIF11 P52732 5/20 0.42
NOS2 P35228 3/20 0.42
NOS1 P29475 2/20 0.42
NOS3 P29474 1/20 0.42
BHMT Q93088 2/20 0.41
BHMT2 Q9H2M3 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC7A11 Q9UPY5 1/20 0.41
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
GRIK1 P39086 1/20 0.38
GRIA2 P42262 1/20 0.38
GRIA4 P48058 1/20 0.38
GRIK3 Q13003 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231968 1.00 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL18818924 0.87 SLC7A5 (0.45) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL28948326 0.84 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL6542263 0.84 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL13988062 0.84 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL6542267 0.84 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL13902860 0.84 SLC7A5 (0.50) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
Hydrochloric Acid SCHEMBL9463162 0.82 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
Hydrochloric Acid SCHEMBL9462892 0.82 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1ARG1
SCHEMBL15600074 0.80 SLC7A5 (0.46) SLC7A5SLC1A3SLC1A2SLC1A1ARG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1282397-B1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT OREAL (FR) 2005-05-04 EP claimed
US-20040037856-A1 Use of compounds containing a thio-ether, sulphoxide or sulphone function as cosmetic anti-pollution agent L'OREAL (FR) 2004-02-26 US claimed
EP-0858319-B1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION OREAL (FR) 2003-07-23 EP claimed
EP-1282397-A1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT L'OREAL (FR) 2003-02-12 EP claimed
WO-2001087261-A1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT L'OREAL (FR) 2001-11-22 WO claimed
US-6153649-A Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration L'OREAL (FR) 2000-11-28 US claimed
EP-0858319-A1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION L'OREAL (FR) 1998-08-19 EP claimed
WO-1997016165-A1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION L'OREAL (FR) 1997-05-09 WO claimed
WO-2010111789-A1 INHIBITION OF FORMATION OF ADVANCED GLYCATION ENDPRODUCTS UNIVERSITY OF SASKATCHEWAN (CA) 2010-10-07 WO disclosed
EP-1282397-B1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT OREAL (FR) 2005-05-04 EP disclosed
US-20040037856-A1 Use of compounds containing a thio-ether, sulphoxide or sulphone function as cosmetic anti-pollution agent L'OREAL (FR) 2004-02-26 US disclosed
EP-0858319-B1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION OREAL (FR) 2003-07-23 EP disclosed
EP-1282397-A1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT L'OREAL (FR) 2003-02-12 EP disclosed
WO-2001087261-A1 USE OF COMPOUNDS CONTAINING A THIO-ETHER, SULPHOXIDE OR SULPHONE FUNCTION AS COSMETIC ANTI-POLLUTION AGENT L'OREAL (FR) 2001-11-22 WO disclosed
US-6153649-A Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration L'OREAL (FR) 2000-11-28 US disclosed
EP-0858319-A1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION L'OREAL (FR) 1998-08-19 EP disclosed
WO-1997016165-A1 USE OF CARBOXYLIC ACIDS HAVING A SULPHUR FUNCTION FOR PROMOTING SKIN EXFOLIATION OR STIMULATING EPIDERMAL REGENERATION L'OREAL (FR) 1997-05-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040037856-A1 Use of compounds containing a thio-ether, sulphoxide or sulphone function as cosmetic anti-pollution agent TST, STS, MPST SLC7A5 3044/4885SLC1A3 4502/4885SLC1A2 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.